Sylvain Fanier, Msc. EMBA Jean-François Chatal, MD, PhD, Sébastien Avila, PhD Eng, Patrick Breau
President, CEO Co-Founder, Chief Medical Officer Co-Founder, Chief Technical Officer (CTO) Chief Reg. Affairs – Head Pharmacist
Entrepreneur with over 30 years of experience (JNJ, BARD, LEMERPAX, CARDIOINSIGHT, SONOSCANNER, MED-INNOV …). SF has managed from concept to worldwide commercialization of disruptive medical innovations. Pioneer in nuclear medicine, former head of nuclear medicine department at the University Hospital and the cancer center in Nantes, professor emeritus of nuclear medicine at the University of Nantes, director of a research laboratory in cancerology and immunology; founded ATLAB in 2008 sold to TELIX in 2018. Expert in R&D and industrial development of nuclear medicine technology and radiopharmaceutical solutions. 17+ years of experience in the pharmaceutical industry in France and in Africa for international laboratories.

His career has covered all stages of the life cycle of a drug, from R&D for IPSEN, to production and packaging for SANOFI, as well as distribution/marketing for a generic subsidiary of Novartis.